ABSTRACT
Background
The current NCCN recommendation for resection margins in patients with melanomas between 1.01 and 2 mm deep is a 1–2 cm radial margin. We sought to determine whether margin width had an impact on local recurrence (LR), disease-specific survival (DSS), and type of wound closure.
Methods
Melanomas measuring 1.01–2.0 mm were evaluated at a single institution between 2008 and 2013. All patients had a 1 or 2 cm margin.
Results
We identified 965 patients who had a 1 cm (n = 302, 31.3 %) or 2 cm margin (n = 663, 68.7 %). Median age was 64 years, and 592 (61.3 %) were male; 32.5 and 48.7 % of head and neck and extremity patients had a 1 cm margin versus 18.9 % of trunk patients (p < 0.001). LR was 2.0 and 2.1 % for a 1 and 2 cm margin, respectively (p = not significant). Five-year DSS was 87 % for a 1 cm margin and 85 % for a 2 cm margin (p = not significant). Breslow thickness, melanoma on the head and neck, lymphovascular invasion, and sentinel lymph node biopsy (SLNB) status significantly predicted LR on univariate analysis; however, only location and SLNB status were associated with LR on multivariate analysis. Margin width was not significant for LR or DSS. Wider margins were associated with more frequent graft or flap use only on the head and neck (p = 0.025).
Conclusions
Our data show that selectively using a narrower margin of 1 cm did not increase the risk of LR or decrease DSS. Avoiding a 2 cm margin may decrease the need for graft/flap use on the head and neck.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
Cascinelli N. Margin of resection in the management of primary melanoma. Semin Surg Oncol. 1998;14:272–5.
Cohen-Cedermark G, Rutqvist LE, Andersson R, et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer. 2000;89:1495–501.
Balch CM, Soong SJ, Ross MI, et al. Long-term results of a prospective trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol. 2001;8:101–8.
Khayat D, Rixe O, Martin G, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer. 2003;97:1941–6.
Gillgren P, Drzewiecki KT, Niin M, et al. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial. Lancet. 2011;378:1635–42.
Thomas JM, Newton-Bishop J, A’Hern R, et al. Excision margins in high-risk malignant melanoma. N Engl J Med. 2004;350:757–66.
Grotz TE, Markovic SN, Erickson LA, et al. Mayo clinic consensus recommendations for the depth of excision in primary cutaneous melanoma. Mayo Clinic Proc. 2011;86:522–8.
Veronesi U, Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg. 1991;126:438–41.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Melanoma, version 1.2013. National Comprehensive Cancer Network, Fort Washington, PA. www.NCCN.org, 2013.
Hudson LE, Maithel SK, Carlson GW, et al. 1 or 2 cm margins of excision for T2 melanomas: do they impact recurrence or survival? Ann Surg Oncol. 2013;20:346–51.
Lens MB, Dawes M, Goodacre T, et al. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow versus wide excision. Arch Surg. 2002; 137:1101–6.
Balch CM, Gershenwald JE, Soong S, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–206.
Ott PA, Berman RS. Surgical approach to primary cutaneous melanoma. Surg Oncol Clin N Am. 2011;20:39–56.
Haydu LE, Stollman JT, Scolyer RA, et al. Minimum safe pathologic excision margins for primary cutaneous melanomas (1–2 mm in thickness): analysis of 2131 patients treated at a single center. Ann Surg Oncol. 2015:1–11.
Melmar T. Melanoma trial investigating 1-cm vs. 2-cm wide excision margins for primary cutaneous melanoma. https://clinicaltrials.gov. 5 Mar 2015.
Disclosures
Consulting fees and research support has been provided to Jonathan S. Zager by Amgen, Castle Biosciences and Provectus. Grant support and medical advisory board for Delcath Systems.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Doepker, M.P., Thompson, Z.J., Fisher, K.J. et al. Is a Wider Margin (2 cm vs. 1 cm) for a 1.01–2.0 mm Melanoma Necessary?. Ann Surg Oncol 23, 2336–2342 (2016). https://doi.org/10.1245/s10434-016-5167-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-016-5167-6